Oxcarbazepine: Difference between revisions
| [checked revision] | [checked revision] |
MDElliottMD (talk | contribs) Comprehensive categorization: +Sodium channel blockers, Anticonvulsants / Antiepileptics, Mood Stabilizers |
MDElliottMD (talk | contribs) Dedupe migration per interface-claude 2026-05-20: Anticonvulsants / Antiepileptics merged into canonical Anticonvulsants. Member retagged. |
||
| Line 33: | Line 33: | ||
[[Category:Mood_Stabilizers]] | [[Category:Mood_Stabilizers]] | ||
[[Category:Sodium channel blockers]] | [[Category:Sodium channel blockers]] | ||
[[Category:Anticonvulsants | [[Category:Anticonvulsants]] | ||
[[Category:Mood Stabilizers]] | [[Category:Mood Stabilizers]] | ||
Revision as of 18:00, 19 May 2026
Mood Stabilizer, Anticonvulsant
Oxcarbazepine
Trileptal
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
No titration strategies yet. Be the first to suggest one.
Effects
No effects listed yet. Be the first to suggest one.
Interactions
Pharmacogenomic + mechanism interactions
Pharmacogenomic guideline recommendationsCPIC and Dutch Pharmacogenetics Working Group clinical guidelines
CPIC rec 8094683 [Strong]: If patient is oxcarbazepine-naïve, do not use oxcarbazepine. CPIC pair-level A (HLA-A, HLA-B and Carbamazepine and Oxcarbazepine) [PMID 29392710]
Rate this interaction. Reports are anonymous and help curate the page.
Clinical relevance: does this interaction matter in practice?trivialcritical
Mechanism description, if it needs work:
Is this row worth surfacing?
Your own experience with this combination:
Experience (1 a little, 5 a lot)
Outcome (-100 worst, +100 best)
CPIC rec 8094685 [Optional]: The latency period for drug-induced SJS/TEN is short with continuous dosing and adherence to therapy (~4-28 days), and cases usually occur within three months of dosing; therefore, if the patient has previously used oxcarbazepine consistently for longer than three months without incidence of cutaneous adverse reactions, cautiously consider use of oxcarbazepine in the future. CPIC pair-level A (HLA-A, HLA-B and Carbamazepine and Oxcarbazepine) [PMID 29392710]
Rate this interaction. Reports are anonymous and help curate the page.
Clinical relevance: does this interaction matter in practice?trivialcritical
Mechanism description, if it needs work:
Is this row worth surfacing?
Your own experience with this combination:
Experience (1 a little, 5 a lot)
Outcome (-100 worst, +100 best)
Patient experience
No patient-experience reports yet.
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Pharmacy
Common uses
Classification(s)
Classes
Mood Stabilizer, Anticonvulsant
Pharmacology
Purported mechanism
Sodium channel blocker